Gilead Sciences (GILD) Net Margin (2009 - 2026)
Gilead Sciences' Net Margin was -134.51% in Q2 2026, down 162.19 percentage points from 27.68% a year earlier and down 163.55 percentage points from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Net Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gilead Sciences' Net Margin was -10.64% through Jun 30, 2026, down 32.50 percentage points year-over-year; for FY2025, it was 28.90%, up 27.23 percentage points from FY2024.
- Net Margin shows a five-year change of +28.41 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was 1.67% in FY2024 (-19.22 pp), 20.89% in FY2023 (+4.06 pp), 16.83% in FY2022 (-5.97 pp) and 22.80% in FY2021 (+22.30 pp).
- The Q2 2026 figure marks the lowest quarterly Net Margin in data going back to Q1 2009.
- Compared with a year earlier, Net Margin was higher in six of the last eight quarters, with an average year-over-year change of -6.31 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q1 2025 (a gain of 82.09 percentage points); the worst was Q2 2026 (a drop of 162.19 percentage points).
- Per Business Quant data, GILD's Net Margin in the three quarters before Q2 2026 was 29.04% (Q1 2026), 27.55% (Q4 2025) and 39.28% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 22.61% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 18.81% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -1.65% |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 32.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -134.51% |
| Mar 31, 2026 | 29.04% |
| Dec 31, 2025 | 27.55% |
| Sep 30, 2025 | 39.28% |
| Jun 30, 2025 | 27.68% |
| Mar 31, 2025 | 19.72% |
| Dec 31, 2024 | 23.56% |
| Sep 30, 2024 | 16.61% |
| Jun 30, 2024 | 23.21% |
| Mar 31, 2024 | -62.37% |
| Dec 31, 2023 | 20.09% |
| Sep 30, 2023 | 30.92% |
| Jun 30, 2023 | 15.84% |
| Mar 31, 2023 | 15.90% |
| Dec 31, 2022 | 22.20% |
| Sep 30, 2022 | 25.40% |
| Jun 30, 2022 | 18.27% |
| Mar 31, 2022 | 0.29% |
| Dec 31, 2021 | 5.27% |
| Sep 30, 2021 | 34.93% |
API Access
Gilead Sciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();